| Joe David May, M D | |
|
8072 Ironstone Dr, Alexander, AR 72002-5007 | |
| (501) 332-1000 | |
| (501) 332-1042 |
| Full Name | Joe David May |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Location | 8072 Ironstone Dr, Alexander, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316230816 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | E-7781 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joe David May, M D 8072 Ironstone Dr, Alexander, AR 72002-5007 Ph: (501) 332-1000 | Joe David May, M D 8072 Ironstone Dr, Alexander, AR 72002-5007 Ph: (501) 332-1000 |
News Archive
Female surgeons at a large academic medical center perform less complex surgical procedures than their male counterparts, according to a new study by researchers at Massachusetts General Hospital.
Dengue is a mosquito-transmitted viral infection. The disease is widespread in tropical and sub-tropical climates and most commonly found in urban areas. Around half of the world's population are now estimated to live in dengue endemic regions.
Patients with type 2 diabetes fare significantly better if they are started on three medications at the time of diagnosis than if they are prescribed a single drug and have other therapies added later, a San Antonio researcher said June 22 at the 73rd Scientific Sessions of the American Diabetes Association in Chicago.
Testimony will come from the nation's largest physician organizations, which will tell a House subcommittee about the need to replace Medicare's current payment system. Meanwhile, on the personnel front, the Centers for Medicare and Medicaid Services has a new chief medical officer and Berwick is talking about his "service."
BIOASIS TECHNOLOGIES INC., a pioneering biopharmaceutical company focused on overcoming the limitations of therapeutic drug delivery across the blood-‐brain barrier (BBB), announces the results from an animal ischemic stroke model performed at the National Research Council Canada with the biOasis Transcend carrier peptide, MTfp and siRNA (MTfp-‐siRNA).
› Verified 4 days ago